CLINICAL_TRIALS
trial_result
· 2014-10-07
Clinical Trial Update: A Study of ICT-107 Immunotherapy in Glioblastoma Multiforme (GBM) [Phase 2]
Summary
Phase 2 clinical trial update of ICT-107 immunotherapy in glioblastoma multiforme; results were posted in 2014.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Precision Life Sciences Group | Conditions: Glioblastoma Multiforme | Phase 2 | Status: COMPLETED | Results posted: 2014-10-07